Reliant AI

Reliant AI is a provider of generative AI-powered data analytics software designed to accelerate secondary research within the biopharma industry. Founded in 2023 by Karl Moritz Hermann, Marc Bellemare, and Richard Schlegel, who are renowned scientists and researchers with prior leadership experience at prominent organizations such as DeepMind, Google Brain, and EY Parthenon, the company aims to address significant information challenges. Reliant AI is driven by a passion for leveraging generative AI to reduce repetitive mental labor and expedite decision-making processes for enterprises. The company's core mission is to empower knowledge workers by enabling them to focus on critical tasks rather than time-consuming menial mental work. They achieve this by developing technology that allows for the joint analysis of structured and unstructured data through a unified interface, ultimately leading to improved and faster decision-making. Reliant AI has offices in Montreal, Canada, and Berlin, Germany, reflecting its international presence and commitment to serving a global market. The company has secured substantial seed funding to support its growth, including hiring engineering talent and expanding its technological footprint in both Europe and North America.

Reliant AI's flagship product, Reliant Tabular, is an AI workbench specifically tailored for the life sciences sector. This platform assists life science analysts in discovering scientific evidence to support their decisions by automating systematic reviews, conducting asset scans, performing comprehensive analyses, and offering a customizable data platform. Key features of Reliant Tabular include proprietary machine learning models optimized for biopharma topics, a comprehensive approach to fact-finding to ensure thoroughness, and a user interface designed for easy reconciliation of generated results with ground truth evidence. The platform also provides answers in a report-ready format to facilitate team collaboration. Reliant AI emphasizes its commitment to data privacy, stating that its algorithms learn from open-access publications and databases rather than client data. The company's solutions are geared towards simplifying the labor-intensive process of collecting, organizing, and inspecting vast amounts of complex data, allowing users to derive decision-critical insights with confidence. By blending cutting-edge AI research with domain expertise, Reliant AI seeks to significantly reduce the time spent on data wrangling, thereby enhancing productivity and accelerating innovation in the biopharma industry. The company was named to the CB Insights' 2025 list of the 100 Most Innovative AI Startups.